2019-04-01·Antimicrobial agents and chemotherapy2区 · 医学
In VitroActivity of a Novel Antifungal Compound, MYC-053, against Clinically Significant Antifungal-Resistant Strains ofCandida glabrata,Candida auris,Cryptococcus neoformans, andPneumocystisspp
2区 · 医学
Article
作者: Tetz, G. ; Tetz, V. ; Vikina, D. ; Collins, M.
An urgent need exists for new antifungal compounds to treat fungal infections in immunocompromised patients. The aim of the current study was to investigate the potency of a novel antifungal compound, MYC-053, against the emerging yeast and yeast-like pathogensCandida glabrata,Candida auris,Cryptococcus neoformans, andPneumocystisspecies.